Overview
The Role of Endothelin in Pulmonary Hypertension
Status:
Completed
Completed
Trial end date:
2011-06-01
2011-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of the study is is to determine the effect, on the lung circulation, of BQ-123, an investigational compound which is not approved by the FDA.Phase:
Phase 2Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Brigham and Women's HospitalTreatments:
cyclo(Trp-Asp-Pro-Val-Leu)
Criteria
Inclusion Criteria:- Healthy volunteers or known diagnosis of pulmonary hypertension
Exclusion Criteria:
- hypertension due to other reasons (not pulmonary)